| For: | Atwa SM, Handoussa H, Hosny KM, Odenthal M, El Tayebi HM. Pivotal role of long non-coding ribonucleic acid-X-inactive specific transcript in regulating immune checkpoint programmed death ligand 1 through a shared pathway between miR-194-5p and miR-155-5p in hepatocellular carcinoma. World J Hepatol 2020; 12(12): 1211-1227 [PMID: 33442449 DOI: 10.4254/wjh.v12.i12.1211] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i12/1211.htm |
| Number | Citing Articles |
| 1 |
Jakub Litak, Wiesława Grajkowska, Jacek Bogucki, Paweł Kowalczyk, Alicja Petniak, Arkadiusz Podkowiński, Justyna Szumiło, Janusz Kocki, Jacek Roliński, Mansur Rahnama-Hezavah, Marcin Roszkowski, Cezary Grochowski. PD-L1/miR-155 Interplay in Pediatric High-Grade Glioma. Brain Sciences 2022; 12(3) doi: 10.3390/brainsci12030324
|
| 2 |
Long non-coding RNAs (lncRNAs) in hepatocellular carcinoma progression: Biological functions and new therapeutic targets. Progress in Biophysics and Molecular Biology 2023; 177 doi: 10.1016/j.pbiomolbio.2022.12.004
|
| 3 |
Israa M. Helal, Monica A. Kamal, Mostafa K. Abd El-Aziz, Hend M. El Tayebi. Epigenetic tuning of tumour-associated macrophages (TAMs): a potential approach in hepatocellular carcinoma (HCC) immunotherapy. Expert Reviews in Molecular Medicine 2024; 26 doi: 10.1017/erm.2024.9
|
| 4 |
Ting Xu, Gaoxiang Chen. Oleuropein Regulates GSDME Methylation to Inhibit Tumor Growth and Enhance Radiosensitivity in Head and Neck Squamous Cell Carcinoma Via Inducing Pyroptosis. Applied Biochemistry and Biotechnology 2026; doi: 10.1007/s12010-026-05763-1
|
| 5 |
Yibei Gui, Jiale Zhao, Wei Wu, Xueqing Li, Lijun Wang, Hailin Wang, Yiyang Luo, Xueliang Ding, Xiaolan Li, Chengfu Yuan. TSIX: A Novel Long Noncoding RNA in Cancer Development and Progression. Current Pharmaceutical Design 2026; 32(8) doi: 10.2174/0113816128373990250609210655
|
| 6 |
Wenxiao Jiang, Shuya Pan, Xin Chen, Zhi-wei Wang, Xueqiong Zhu. The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy. Molecular Cancer 2021; 20(1) doi: 10.1186/s12943-021-01406-7
|
| 7 |
Sepideh Maralbashi, Cynthia Aslan, Houman Kahroba, Milad Asadi, Mohammad Sadegh Soltani-Zangbar, Navideh Haghnavaz, Farhad Jadidi, Farhad Salari, Tohid Kazemi. Docosahexaenoic acid (DHA) impairs hypoxia-induced cellular and exosomal overexpression of immune-checkpoints and immunomodulatory molecules in different subtypes of breast cancer cells. BMC Nutrition 2024; 10(1) doi: 10.1186/s40795-024-00844-y
|
| 8 |
Chen Xue, Xinyu Gu, Zhengyi Bao, Yuanshuai Su, Juan Lu, Lanjuan Li. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.847728
|
| 9 |
Andrea del Saz-Lara, María-Carmen López de las Hazas, Francesco Visioli, Alberto Dávalos. Nutri-Epigenetic Effects of Phenolic Compounds from Extra Virgin Olive Oil: A Systematic Review. Advances in Nutrition 2022; 13(5) doi: 10.1093/advances/nmac067
|
| 10 |
Liyuan Hao, Shenghao Li, Jiali Deng, Na Li, Fei Yu, Zhi Jiang, Junli Zhang, Xinli Shi, Xiaoyu Hu. The current status and future of PD-L1 in liver cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1323581
|
| 11 |
Mai A. Abd-Elmawla, Yumn A. Elsabagh, Nora M. Aborehab. Association of XIST/miRNA155/Gab2/TAK1 cascade with the pathogenesis of anti-phospholipid syndrome and its effect on cell adhesion molecules and inflammatory mediators. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-45214-z
|
| 12 |
Subhas Das, Soumyabrata Chatterjee, Tushar Patel, Soma Banerjee. RNA renaissance: Harnessing non-coding RNA therapeutics for hepatocellular carcinoma. Pharmacology & Therapeutics 2026; 277 doi: 10.1016/j.pharmthera.2025.108956
|
| 13 |
Chengzhi Wang, Xin Li, Lijuan Zhang, Ying Chen, Ruijie Dong, Jieyou Zhang, Jingyi Zhao, Xiangdong Guo, Guangze Yang, Yan Li, Chao Gu, Qing Xi, Rongxin Zhang. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer. International Immunopharmacology 2021; 97 doi: 10.1016/j.intimp.2021.107822
|
| 14 |
Radwa Y. Mekky, Mai F. Ragab, Tamer Manie, Abdelrahman A. Attia, Rana A. Youness. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer. Translational Oncology 2023; 31 doi: 10.1016/j.tranon.2023.101653
|
| 15 |
José Luis García-Giménez, Wiam Saadi, Angel L. Ortega, Agustin Lahoz, Guillermo Suay, Julián Carretero, Javier Pereda, Ahlam Fatmi, Federico V. Pallardó, Salvador Mena-Molla. miRNAs Related to Immune Checkpoint Inhibitor Response: A Systematic Review. International Journal of Molecular Sciences 2024; 25(3) doi: 10.3390/ijms25031737
|
| 16 |
Lei Wang, Qiu‐Mei Cao. Long non‐coding RNA XIST alleviates sepsis‐induced acute kidney injury through inhibiting inflammation and cell apoptosis via regulating miR‐155‐5p/WWC1 axis. The Kaohsiung Journal of Medical Sciences 2022; 38(1) doi: 10.1002/kjm2.12442
|
| 17 |
Eman A. Al-Sharabass, Motawa E. EL-Houseini, Heba Effat, Sherif Abdelaziz Ibrahim, Mona S. Abdellateif. The clinical potential of PDL-1 pathway and some related micro-RNAs as promising diagnostic markers for breast cancer. Molecular Medicine 2025; 31(1) doi: 10.1186/s10020-025-01137-1
|